Carcinoma Mucinoso de Mama Triplo Negativo: Relato de Caso

Conteúdo do artigo principal

Ana Beatriz Bisol Duizith
https://orcid.org/0009-0005-4119-5435
Ana Carolina da Costa Corrêa
https://orcid.org/0009-0000-3260-5088
Eloísa Talamini Assef
https://orcid.org/0009-0002-7502-9556
João Gabriel Vicentini Karvat
https://orcid.org/0000-0002-7042-8147
João Henrique e Silva Costa
https://orcid.org/0009-0009-8122-1596
Marina Guimarães Gunther
https://orcid.org/0000-0003-2084-860X
Maria Cristina Figueroa Magalhães

Resumo

O carcinoma mucinoso da mama (CMM) é um tipo histológico raro que representa de 1% a 6% das neoplasias de mama, sendo mais frequente em mulheres idosas e apresentando em geral bom prognóstico. Este trabalho relata o caso de uma paciente de 52 anos que apresentou, inicialmente, quadro de edema associado a mastalgia e retração papilar em mama esquerda, admitida em nosso serviço apenas com mamografia de rotina. Exames de estadiamento iniciais e biópsia acrescida de imuno-histoquímica com subsequente necessidade de ampliação de painel sugeriram inicialmente sítio primário em trato gastrointestinal, contudo investigação posterior revelou tratar-se de uma neoplasia primária de mama mucinosa triplo negativa. Assim, este relato descreve um caso incomum de CMM triplo negativo, havendo poucos exemplares semelhantes na literatura, bem como sua investigação, diagnóstico definitivo, tratamentos instituídos e resposta terapêutica.

Detalhes do artigo

Como Citar
Duizith, A. B. B., Corrêa, A. C. da C., Assef, E. T., Karvat, J. G. V., Costa, J. H. e S., Gunther, M. G., & Magalhães, M. C. F. (2026). Carcinoma Mucinoso de Mama Triplo Negativo: Relato de Caso. Brazilian Journal of Case Reports, 6(1), bjcr154. https://doi.org/10.52600/2763-583X.bjcr.2026.6.1.bjcr154
Seção
Clinical Case Reports
Biografia do Autor

Ana Beatriz Bisol Duizith, Pontifícia Universidade Católica do Paraná (PUCPR)

Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brasil.

Ana Carolina da Costa Corrêa, Pontifícia Universidade Católica do Paraná (PUCPR)

Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brasil.

Eloísa Talamini Assef, Pontifícia Universidade Católica do Paraná (PUCPR)

Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brasil.

João Gabriel Vicentini Karvat, Pontifícia Universidade Católica do Paraná (PUCPR)

Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brasil.

João Henrique e Silva Costa, Hospital Universitário Evangélico Mackenzie (HUEM)

Hospital Universitário Evangélico Mackenzie (HUEM), Curitiba, Paraná, Brasil.

Marina Guimarães Gunther, Pontifícia Universidade Católica do Paraná (PUCPR)

Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brasil.

Maria Cristina Figueroa Magalhães, Hospital Universitário Evangélico Mackenzie (HUEM)

Hospital Universitário Evangélico Mackenzie (HUEM), Curitiba, Paraná, Brasil.

Referências

Budzik MP, Fudalej MM, Badowska-Kozakiewicz AM. Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special type. Sci Rep. 2021 Mar 11;11(1):5772.

Bregni G, Bertoli G, Casoli L, Brioschi E, Tettamanti S, Magni E, et al. Unraveling biomarker signatures in triple-negative breast cancer: a systematic review for targeted approaches. Int J Mol Sci. 2024 Feb 22;25(5):2559.

Chen WY, Chen CS, Chen HC, Hung YJ, Chu JS. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma. Pathol Int. 2004 Oct;54(10):781–6.

Chen X, Liu D, Lu B, Gao Q, Zhao H, Li J, et al. Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer. Breast. 2024 Jun 20;75:103760.

Coeli GNM, Reis HF, Bertinetti DR, Faria FM, Tiezzi DG, Oliveira TMG. Mucinous carcinoma of the breast: iconographic essay with histopathological correlation. Radiol Bras. 2013;46:242–6.

De Falco V, Ciardo G, Cozzolino I, Troiani T. Unraveling biomarker signatures in triple-negative breast cancer: a systematic review for targeted approaches. Cancers (Basel). 2024 Mar 8;16(6):1043.

Deng Y, Xue D, Wang X, Xu S, Ao Q, Hu Z, et al. Mucinous cystadenocarcinoma of the breast with a basal-like immuno-phenotype. Pathol Int. 2012 Mar;62(6):429–32.

Gulwani H, Bhalla S. Mucinous cystadenocarcinoma: a rare primary malignant tumor of the breast. Indian J Pathol Microbiol. 2010;53(1):200–2.

Domoto H, Terahata S, Yamazaki T, Sato K, Takeo H, Tamai S. Mucinous cystadenocarcinoma of the breast showing sulfomucin production. Histopathology. 2000 Jun;36(6):567–9.

Honma N, Sakamoto G, Ikenaga M, Kuroiwa K, Younes M, Takubo K. Mucinous cystadenocarcinoma of the breast: a case report and review of the literature. Arch Pathol Lab Med. 2003 Aug;127(8):1031–3.

Jain E, Kumar A, Jain R, Sharma S. Primary mucinous cystadenocarcinoma of the breast: a rare case report with review of literature. Int J Surg Pathol. 2021 Feb;29(7):740–6.

Kim SE, Park JH, Hong SW, Koo JS, Jeong J, Jung WH. Primary mucinous cystadenocarcinoma of the breast: cytologic finding and expression of MUC5 are different from mucinous carcinoma. Korean J Pathol. 2012;46(6):611–6.

Koenig C, Tavassoli FA. Mucinous cystadenocarcinoma of the breast. Am J Surg Pathol. 1998 Jun;22(6):698–703.

Koufopoulos N, Goudeli C, Syrios J, Filopoulos E, Khaldi L. Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity. Rare Tumors. 2017 Oct 3;9(3):7016.

Kucukzeybek BB, Yigit S, Sari AA, Rezanko T, Durak E, Sadullahoglu C. Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH: case report and review of the literature. Pol J Pathol. 2014;65(1):70–3.

Leal MCP. Avaliação prognóstico e características anatomoclínicas do carcinoma mucinoso da mama [dissertation]. 2009. 73 p.

Lin LH, Hernandez O, Zhu K, Guth A, Cotzia P, Darvishian F. Genetic profile of primary mucinous cystadenocarcinoma of the breast: a case report. Breast J. 2021 Sep;27(9):731–4.

Lin DL, Hu JL, Shao SH, Sun DM, Wang JG. Primary mucinous cystadenocarcinoma of the breast with endocervical-like mucinous epithelium. Breast Care (Basel). 2013;8(6):445–7.

Lu K, Wang X, Zhang W, Ye H, Lao L, et al. Clinicopathological and genomic features of breast mucinous carcinoma. Breast. 2020 Aug;53:130–7.

Nayak A, Bleiweiss IJ, Dumoff K, Bhuiya TA. Mucinous cystadenocarcinoma of the breast: report of 2 cases including one with long-term local recurrence. Int J Surg Pathol. 2018 Dec;26(8):749–57.

Petersson F, Pang B, Thamboo TP, Putti TC. Mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH: the first case reported. Hum Pathol. 2010 Jun;41(6):910–3.

Rakıcı S, Gönüllü G, Gürsel SB, Yıldız L, Bayrak IK, Yücel İ. Mucinous cystadenocarcinoma of the breast with estrogen receptor expression: a case report and review of the literature. Case Rep Oncol. 2009;2(3):210–6.

Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 2010 Sep 2;12:R86.

Sentani K, Tashiro T, Uraoka N, Aosaki Y, Yano S, Takaeko F, et al. Primary mammary mucinous cystadenocarcinoma: cytological and histological findings. Diagn Cytopathol. 2012 Jul;40(7):624–8.

Seong M, Ko EY, Han BK, Cho SY, Cho EY, Lee SK, et al. Radiologic findings of primary mucinous cystadenocarcinoma of the breast: a report of two cases and a literature review. J Breast Cancer. 2016 Sep;19(3):330–3.

Wang X, Li Y, Zhao P, Jia H, Dong X, Zhang L, et al. Primary mucinous cystadenocarcinoma of the breast: a clinicopathologic analysis of one case and review of the literature. Int J Clin Exp Pathol. 2020 Oct;13(10):2562–8.

Witherspoon LE, Oxenhandler RW. A rare tumor: mucinous cystadenocarcinoma of the breast. Am Surg. 2015 Mar;81(3):E106–8.